$65.00
Note: Shipped In Freeze Dried Lyophilized Form – Requires Reconstitution
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Not for human consumption
Retatrutide (also known as LY-3437943) is a novel synthetic peptide designed as a triple receptor agonist for the GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors. This unique multi-target profile makes it a valuable tool for in vitro and preclinical studies focused on metabolic signaling pathways, receptor activation dynamics, and energy-regulation mechanisms. Retatrutide is supplied as a white to off-white lyophilized powder with high sequence fidelity and verified purity, suitable for laboratory assays, receptor binding studies, signal transduction research, and peptide-based metabolic science investigations.
Supplied as a 10 mg vial, Retatrutide provides a reliable peptide substrate for advanced experimental work in metabolic disease models, endocrine signaling pathways, and peptide biology research. This compound is intended for scientific use only and is not for human or animal consumption, diagnostic, therapeutic, or veterinary use.
